Fibrinolysis Before Cardiopulmonary Bypass?
NCT01981863
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Pathologic Fibrinolysis
Interventions
DRUG:
Epsilonaminocaproic acid
DRUG:
Placebo
Sponsor
Stanford University